Status:
WITHDRAWN
A Comparative Trial of TMS Approaches to Treating Depression
Lead Sponsor:
The University of New South Wales
Conditions:
Depression
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
Trancranial Magnetic Stimulation (TMS) is a non-drug and non-invasive treatment for depression and has been investigated for the treatment of psychiatric illness for over 15 years. There is now establ...
Eligibility Criteria
Inclusion
- Age ≥18 years.
- DSM-IV diagnosis of current Major Depressive Episode.
- MADRS score of 20 or more.
- Able to give informed consent.
Exclusion
- DSM-IV psychotic disorder.
- Drug or alcohol abuse or dependence (preceding 3 months).
- Inadequate response to ECT (current episode of depression).
- Rapid clinical response required, e.g. high suicide risk.
- Significant neurological disorder, which may pose increased risks with TMS, e.g., epilepsy.
- Metal in the cranium, skull defects, pacemaker, cochlear implant, medication pump or other electronic device.
- Pregnancy.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01906905
Start Date
June 1 2013
End Date
December 1 2013
Last Update
April 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Black Dog Institute, University of New South Wales
Sydney, New South Wales, Australia, 2052